MoneyWorks4Me

The revenue zoomed 24.42% to Rs. 351.99 millions for the quarter ended March 2023 as compared to Rs. 282.90 millions during the corresponding quarter last year.Net profit surges 84.28% to Rs. 63.54  millions  from Rs. 34.48 millions in the quarter ended March 2023.Operating profit for the quarter ended March 2023 rose to 87.54 millions as compared to 59.30 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202203 202103 % Var
Sales 351.99 282.90 24.42 1367.49 1239.80 10.30 1239.80 1092.94 13.44
Other Income 12.56 12.78 -1.72 51.24 49.49 3.54 49.49 43.08 14.88
PBIDT 87.54 59.30 47.62 354.91 322.02 10.21 322.04 241.52 33.34
Interest 0.84 1.21 -30.58 3.67 4.34 -15.44 4.35 4.74 -8.23
PBDT 86.70 58.09 49.25 351.24 317.68 10.56 317.69 236.78 34.17
Depreciation 5.94 5.38 10.41 22.58 18.99 18.90 18.99 20.35 -6.68
PBT 80.76 52.71 53.22 328.66 298.69 10.03 298.70 216.43 38.01
TAX 17.22 18.23 -5.54 82.58 75.74 9.03 75.74 51.39 47.38
Deferred Tax 1.62 4.73 -65.75 -2.25 2.96 -176.01 2.96 -3.91 -175.70
PAT 63.54 34.48 84.28 246.08 222.95 10.37 222.96 165.04 35.09
Equity 44.13 45.89 -3.84 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 24.87 20.96 18.65 25.95 25.97 -0.08 25.98 22.10 17.54
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..